Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) provides access to the company’s official regulatory disclosures, including annual, quarterly and current reports. Through filings such as Form 10-K and Form 10-Q, Petco reports detailed information on its net sales from products and from services and other revenue, gross profit, selling, general and administrative expenses, operating income or loss, interest expense, net income or loss and cash flows. These filings also present balance sheet data covering assets, liabilities and stockholders’ equity, along with information on lease obligations and senior secured credit facilities.
Petco frequently uses Form 8-K to furnish earnings press releases under Item 2.02 (Results of Operations and Financial Condition). These 8-K filings attach full-text earnings releases as exhibits and may also reference scheduled webcasts where management discusses quarterly or annual results. Other 8-K filings report matters such as participation in investor conferences and the results of stockholder votes at the annual meeting, including director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
For investors analyzing WOOF, the SEC filings are a primary source for understanding Petco’s financial performance, capital structure and governance. They detail the company’s use of non-GAAP measures such as Adjusted EBITDA and Free Cash Flow, along with reconciliations to the most comparable GAAP measures. Filings also include discussions of guidance assumptions, risk factors and forward-looking statements related to net sales, earnings outlooks, cost action plans and transformation efforts.
On Stock Titan, these filings are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy documents, highlight key trends in revenue and profitability, and surface information on topics such as debt levels, lease commitments and stockholder voting outcomes. This allows users to review Petco’s historical and current disclosures efficiently while maintaining direct access to the underlying SEC documents.
Petco Health & Wellness Company, Inc. executive Michael Romanko reported a Form 4 transaction showing a tax-related share disposition. On March 4, 2026, 130,194 shares of Class A common stock were withheld at a price of $2.65 per share to satisfy his tax liability on vested restricted stock units granted under the 2021 Equity Incentive Plan. After this withholding, he directly owned 1,190,945 shares of Class A common stock, and this amount includes 871,952 outstanding restricted stock units, each representing the right to receive one share.
Petco Health & Wellness Company, Inc. Chief Revenue Officer Patrick J. Venezia reported a tax-withholding disposition of Class A common stock tied to restricted stock units (RSUs). On March 4, 2026, 32,792 shares were withheld at $2.65 per share to satisfy his tax liability on vesting RSUs granted March 4, 2025 under the company’s 2021 Equity Incentive Plan.
After this withholding transaction, Venezia directly owned 442,056 shares of Petco Class A common stock. His holdings also include 398,832 outstanding RSUs granted under the 2021 Plan, each representing the right to receive one share of Class A common stock.
Petco Health & Wellness Company, Inc. Chief Financial Officer Sabrina Simmons reported tax-related share dispositions of Class A common stock. On March 4, 2026, she delivered 125,036 shares and 65,548 shares at $2.65 per share to satisfy tax liabilities tied to vested restricted stock units.
After these tax-withholding dispositions, she directly owned 1,312,281 shares of Class A common stock. A footnote states this total includes 939,027 outstanding restricted stock units granted under Petco’s 2021 Equity Incentive Plan, each representing the right to receive one share of Class A common stock.
Anderson Joel D reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted its Chief Executive Officer, Joel D. Anderson, a large equity package on February 17, 2026. He received 2,134,388 restricted stock units (RSUs) and 1,400,779 target performance stock units (PSUs) under the 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock or its cash value and vests 34% after one year, then 16.5% at 18, 24, 30 and 36 months from the grant date. The PSUs can pay out between 0% and 200% of the target amount based on a performance period ending February 3, 2029, tied to the company’s 20-day volume-weighted average trading price and subject to continued employment through vesting.
May Holly reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted equity awards to Chief Human Resources Officer Holly May. She received 201,582 restricted stock units on February 17, 2026 under the 2021 Equity Incentive Plan, each representing one share of Class A common stock or its cash value.
The RSUs vest over three years, with 34% after one year and four additional 16.5% installments through the third anniversary of the grant date. She was also granted 132,296 target performance stock units, which can pay out between 0% and 200% of target based on a performance period ending February 3, 2029 and continued employment through vesting.
Venezia Patrick J reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that Chief Revenue Officer Patrick J. Venezia received equity awards in the form of restricted and performance stock units. He was granted 355,732 restricted stock units under the 2021 Equity Incentive Plan on February 17, 2026, each representing one share of Class A common stock or its cash value. These RSUs vest over three years, with 34% after one year and the remaining portions vesting at 18, 24, 30, and 36 months.
Venezia was also granted 233,464 target performance stock units under the same plan. These PSUs can ultimately result in 0% to 200% of the target number of shares, depending on performance over a period ending on February 3, 2029, based on the company’s 20-day volume weighted average trading price and continued employment through vesting.
Romanko Michael reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that Michael Romanko received sizable equity awards under the company’s 2021 Equity Incentive Plan on February 17, 2026. He was granted 711,463 restricted stock units (RSUs), each representing one share of Class A common stock or its cash value.
The RSUs vest over three years, with 34% on the first anniversary of the grant date and four additional tranches of 16.5% through the third anniversary. Romanko also received 466,927 target performance stock units (PSUs), which can pay out from 0% to 200% of the target based on a performance period ending February 3, 2029 and the company’s 20-day volume-weighted average trading price, subject to continued employment.
SIMMONS SABRINA reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted Chief Financial Officer Sabrina Simmons 592,886 restricted stock units (RSUs) and 389,106 performance stock units (PSUs) on February 17, 2026 under its 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock or its cash value and will vest in stages over three years: 34% after one year, then 16.5% at 18 months, two years, 30 months, and three years. The PSUs represent a target that can pay out from 0% to 200% of 389,106 shares based on Petco’s 20-day volume-weighted average trading price over a performance period ending February 3, 2029, and require continued employment through the vesting date.
Insana Giovanni reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that executive Giovanni Insana received equity awards consisting of 189,724 restricted stock units and 124,514 performance stock units under the company’s 2021 Equity Incentive Plan. These awards were granted at a price of $0.00 per unit as part of compensation.
The RSUs vest in stages from the first through the third anniversary of the February 17, 2026 grant date, with 34% vesting after one year and the remaining portions vesting at 18, 24, 30 and 36 months. Each RSU represents one share of Class A common stock or its cash value.
The PSU grant reflects a target of 124,514 units, with the actual number of shares earned ranging from 0% to 200% of target. The final payout will be determined after a performance period ending on February 3, 2029, based on Petco’s 20-day volume-weighted average trading price and continued employment through vesting.
Petco Health & Wellness Company, Inc. Chief Executive Officer and director Joel D. Anderson reported acquiring 5,000 shares of Class A common stock on January 30, 2026 at $2.29 per share under the company’s 2021 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Following this purchase, he beneficially owned 3,231,281 Class A shares directly, which include 2,466,451 restricted stock units where each unit represents one share. He also reported indirect holdings of 853,304 shares by a 2020 Trust, 229,204 shares by a 2025 Trust, 7,874 shares by his son, and 495,706 shares by a Revocable Trust.